Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor- B
Carmen P. Montano‐Almendras, Ahmed Essaghir, Hélène Schoemans, et al.
Haematologica (2012) Vol. 97, Iss. 7, pp. 1064-1072
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Targeting the PDGF signaling pathway in tumor treatment
Carl‐Henrik Heldin
Cell Communication and Signaling (2013) Vol. 11, Iss. 1, pp. 97-97
Open Access | Times Cited: 475
Cytokines in Radiobiological Responses: A Review
Dörthe Schaue, Evelyn L. Kachikwu, William H. McBride
Radiation Research (2012) Vol. 178, Iss. 6, pp. 505-523
Open Access | Times Cited: 367
PDGF receptor signaling networks in normal and cancer cells
Jean‐Baptiste Demoulin, Ahmed Essaghir
Cytokine & Growth Factor Reviews (2014) Vol. 25, Iss. 3, pp. 273-283
Closed Access | Times Cited: 225
World Health Organization‐defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management
Jason Gotlib
American Journal of Hematology (2014) Vol. 89, Iss. 3, pp. 325-337
Closed Access | Times Cited: 192
World Health Organization‐defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management
Jason Gotlib
American Journal of Hematology (2017) Vol. 92, Iss. 11, pp. 1243-1259
Open Access | Times Cited: 191
World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management
William Shomali, Jason Gotlib
American Journal of Hematology (2019) Vol. 94, Iss. 10, pp. 1149-1167
Open Access | Times Cited: 168
World Health Organization‐defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management
Jason Gotlib
American Journal of Hematology (2015) Vol. 90, Iss. 11, pp. 1077-1089
Open Access | Times Cited: 114
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response
Wei Zhang, Yongwei Zhu, Hongyi Liu, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 13
PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations
Amélie I. Velghe, Stéphane Van Cauwenberghe, Anton A. Polyansky, et al.
Oncogene (2013) Vol. 33, Iss. 20, pp. 2568-2576
Open Access | Times Cited: 72
Hematolymphoid Neoplasms Associated With Rearrangements of PDGFRA, PDGFRB, and FGFR1
Francisco Vega, L. Jeffrey Medeiros, Carlos E. Bueso‐Ramos, et al.
American Journal of Clinical Pathology (2015) Vol. 144, Iss. 3, pp. 377-392
Open Access | Times Cited: 59
Population-specific putative causal variants shape quantitative traits
Satoshi Koyama, Xiaoxi Liu, Yoshinao Koike, et al.
Nature Genetics (2024)
Open Access | Times Cited: 5
NFκB signaling regulates embryonic and adult neurogenesis
Yonggang Zhang, Wenhui Hu
Frontiers in Biology (2012) Vol. 7, Iss. 4, pp. 277-291
Open Access | Times Cited: 57
A Minimal Connected Network of Transcription Factors Regulated in Human Tumors and Its Application to the Quest for Universal Cancer Biomarkers
Ahmed Essaghir, Jean‐Baptiste Demoulin
PLoS ONE (2012) Vol. 7, Iss. 6, pp. e39666-e39666
Open Access | Times Cited: 55
World Health Organization‐defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management
Jason Gotlib
American Journal of Hematology (2012) Vol. 87, Iss. 9, pp. 903-914
Open Access | Times Cited: 51
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes
Ling Zhang, Eric Padron, Jeffrey E. Lancet
Leukemia Research (2014) Vol. 39, Iss. 1, pp. 6-17
Closed Access | Times Cited: 46
Receptor Tyrosine Kinases: Translocation Partners in Hematopoietic Disorders
Katelyn N. Nelson, Malalage N. Peiris, April N. Meyer, et al.
Trends in Molecular Medicine (2016) Vol. 23, Iss. 1, pp. 59-79
Closed Access | Times Cited: 32
Beyond Philadelphia
Shai Izraeli
Current Opinion in Hematology (2014) Vol. 21, Iss. 4, pp. 289-296
Closed Access | Times Cited: 33
Causes of hypereosinophilia in 100 consecutive patients
Daniél V. Møller, Julia Tan, Deonne Thaddeus V. Gauiran, et al.
European Journal Of Haematology (2020) Vol. 105, Iss. 3, pp. 292-301
Closed Access | Times Cited: 24
Identification and functional characterization of imatinib‐sensitive DTD1‐PDGFRB and CCDC88C‐PDGFRB fusion genes in eosinophilia‐associated myeloid/lymphoid neoplasms
Darko Gosenca, Beate Kellert, Georgia Metzgeroth, et al.
Genes Chromosomes and Cancer (2014) Vol. 53, Iss. 5, pp. 411-421
Closed Access | Times Cited: 27
ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumors
Angana Biswas, Y. Rajesh, Pralay Mitra, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 1, pp. 188389-188389
Closed Access | Times Cited: 23
STAT5 acetylation
Christian Kosan, Torsten Ginter, Thorsten Heinzel, et al.
JAK-STAT (2013) Vol. 2, Iss. 4, pp. e26102-e26102
Open Access | Times Cited: 24
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes
Stefania Stella, Michele Massimino, Livia Manzella, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 486-486
Open Access | Times Cited: 17
Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers
Yue Gao, Xinyue Wang, Longlong Dong, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 6
IκB Kinase Activity Drives Fetal Lung Macrophage Maturation along a Non-M1/M2 Paradigm
Ashley N. Stouch, Rinat Zaynagetdinov, Whitney Barham, et al.
The Journal of Immunology (2014) Vol. 193, Iss. 3, pp. 1184-1193
Open Access | Times Cited: 21
The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathway
Alexandra Coomans de Brachène, Emeline Bollaert, Astrid Eijkelenboom, et al.
Biochemical Journal (2014) Vol. 460, Iss. 1, pp. 25-36
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top